Clinical Trial Update: Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating weight loss in people with overweight or obesity treated with cagrilintide; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Cagrilintide (cagrilintide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity, Overweight | Phase 3 | Status: ACTIVE_NOT_RECRUITING